MRSH vs. EDIT
MRSH (Marsh & McLennan Companies, Inc) and EDIT (Editas Medicine, Inc.) are both stocks. MRSH operates in Insurance Brokers (Financial Services), while EDIT operates in Biotechnology (Healthcare). Over the past 10 years, MRSH returned 11.75%/yr vs -22.22%/yr for EDIT. At a 0.16 correlation, their price movements are largely independent.
Performance
MRSH vs. EDIT - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, MRSH achieves a -8.15% return, which is significantly lower than EDIT's 21.95% return. Over the past 10 years, MRSH has outperformed EDIT with an annualized return of 11.75%, while EDIT has yielded a comparatively lower -22.22% annualized return.
MRSH
- 1D
- 0.32%
- 1M
- 4.74%
- YTD
- -8.15%
- 6M
- -8.49%
- 1Y
- -20.92%
- 3Y*
- -0.08%
- 5Y*
- 5.55%
- 10Y*
- 11.75%
EDIT
- 1D
- 2.46%
- 1M
- -4.58%
- YTD
- 21.95%
- 6M
- -1.19%
- 1Y
- 26.90%
- 3Y*
- -39.82%
- 5Y*
- -41.79%
- 10Y*
- -22.22%
MRSH vs. EDIT - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
MRSH Marsh & McLennan Companies, Inc | -8.15% | -11.26% | 13.75% | 16.15% | -3.45% | 50.83% | 6.86% | 42.33% | -0.14% | 22.73% |
EDIT Editas Medicine, Inc. | 21.95% | 61.42% | -87.46% | 14.21% | -66.59% | -62.13% | 136.78% | 30.15% | -25.97% | 89.34% |
Correlation
The correlation between MRSH and EDIT is -0.05, meaning there is essentially no relationship between their price movements. Each responds to its own set of market drivers, making them strong candidates for combining in a diversified portfolio.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | -0.05 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.04 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.15 |
Correlation (10Y) Calculated over the trailing 10-year period | 0.17 |
Correlation (All Time) Calculated using the full available price history since Feb 3, 2016 | 0.16 |
The correlation between MRSH and EDIT shifts across timeframes, from -0.05 (1 year) to 0.17 (10 years), reflecting how their relationship changes across market environments.
Fundamentals
MRSH:
$81.98B
EDIT:
$244.70M
MRSH:
$7.99
EDIT:
-$1.21
MRSH:
3.01
EDIT:
6.29
MRSH:
5.54
EDIT:
55.51
MRSH:
$27.52B
EDIT:
$35.86M
MRSH:
$11.66B
EDIT:
$35.86M
MRSH:
$6.68B
EDIT:
-$76.66M
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
MRSH vs. EDIT — Risk / Return Rank
MRSH
EDIT
MRSH vs. EDIT - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Marsh & McLennan Companies, Inc (MRSH) and Editas Medicine, Inc. (EDIT). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| MRSH | EDIT | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -1.08 | ||
| Sortino ratioReturn per unit of downside risk | -2.19 | ||
| Omega ratioGain probability vs. loss probability | 0.85 | 1.11 | -0.27 |
| Calmar ratioReturn relative to maximum drawdown | -0.80 | 0.25 | -1.05 |
| Martin ratioReturn relative to average drawdown | -1.40 | 0.43 | -1.83 |
Loading charts...
Drawdowns
MRSH vs. EDIT - Drawdown Comparison
The maximum MRSH drawdown since its inception was -67.46%, smaller than the maximum EDIT drawdown of -98.92%. Use the drawdown chart below to compare losses from any high point for MRSH and EDIT.
Loading charts...
Drawdown Indicators
| MRSH | EDIT | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -67.46% | -98.92% | +31.46% |
Max Drawdown (1Y)Largest decline over 1 year | -27.01% | -59.88% | +32.87% |
Max Drawdown (3Y)Largest decline over 3 years | -34.36% | -91.18% | +56.82% |
Max Drawdown (5Y)Largest decline over 5 years | -34.36% | -98.66% | +64.30% |
Max Drawdown (10Y)Largest decline over 10 years | -35.80% | -98.92% | +63.12% |
Current DrawdownCurrent decline from peak | -29.62% | -97.24% | +67.62% |
Average DrawdownAverage peak-to-trough decline | -17.41% | -62.63% | +45.22% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 15.50% | 34.03% | -18.53% |
Volatility
MRSH vs. EDIT - Volatility Comparison
The current volatility for Marsh & McLennan Companies, Inc (MRSH) is 6.91%, while Editas Medicine, Inc. (EDIT) has a volatility of 32.34%. This indicates that MRSH experiences smaller price fluctuations and is considered to be less risky than EDIT based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| MRSH | EDIT | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 6.91% | 32.34% | -25.43% |
Volatility (6M)Calculated over the trailing 6-month period | 19.10% | 61.63% | -42.53% |
Volatility (1Y)Calculated over the trailing 1-year period | 23.47% | 94.75% | -71.28% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 20.20% | 94.12% | -73.92% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 20.94% | 83.80% | -62.86% |
Dividends
MRSH vs. EDIT - Dividend Comparison
MRSH's dividend yield for the trailing twelve months is around 2.13%, while EDIT has not paid dividends to shareholders.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
EDIT Editas Medicine, Inc. | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
MRSH Marsh & McLennan Companies, Inc | 2.13% | 1.85% | 1.44% | 1.37% | 1.36% | 1.15% | 1.57% | 1.56% | 1.98% | 1.76% | 1.92% | 2.13% |
Financials
MRSH vs. EDIT - Financials Comparison
This section allows you to compare key financial metrics between Marsh & McLennan Companies, Inc and Editas Medicine, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
Frequently Asked Questions
MRSH and EDIT have a correlation of -0.05, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
EDIT has higher volatility (32.34%) compared to MRSH (6.91%). In terms of maximum drawdown, MRSH dropped -67.46% vs EDIT's -98.92%.
EDIT currently has the higher Sharpe Ratio (0.16 vs -0.93), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for MRSH and EDIT
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer